PetMed Express Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated September 17, 2026, discloses significant changes to the executive leadership and Board of Directors of PetMed Express, Inc. The report details the appointment of a new Chief Executive Officer (CEO) and President, the resignation of the interim CEO and a Board member, and the election of a new Board Chair.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- Executive Appointment: Jeffrey Allen Willard was appointed as CEO, President, and Director. The appointment was approved on August 27, 2026, and becomes effective on September 28, 2026.
- Executive Departure: Leslie C.G. Campbell resigned as Interim CEO, President, and Board member effective September 28, 2026, to pursue retirement plans.
- Board Leadership: Justin Mennen was elected as the new Chair of the Board, effective September 28, 2026. The position of Lead Independent Director was eliminated.
Compensation, Outlook, and Risks
Compensation Arrangements for Jeffrey Allen Willard:
- Base Salary: $550,000 annually, subject to review.
- Signing Bonus: $120,000 (subject to repayment if employment ends within one year).
- Relocation Allowance: $50,000 (subject to sliding scale repayment if employment ends within two years).
- Annual Bonus: Target of 75% of base salary ($412,500) with a maximum of 150% ($825,000).
- Equity Grants:
- Initial Restricted Stock Award (RSA): 250,000 shares vesting in one-third increments over three years.
- Initial Performance Stock Units (PSU): Up to 250,000 units based on three-year total shareholder return relative to the S&P 600 Specialty Retail Index.
- Future Annual Grants: Target aggregate value of $750,000 (50% RSA, 50% PSU).
- Severance:
- Standard Termination (without Cause/Good Reason): 12 months of base salary plus COBRA reimbursement.
- Change of Control (within 12 months): 24 months of base salary plus 18 months COBRA reimbursement.
- Change of Control (before 24-month anniversary): One-time cash bonus of $1,500,000 if the transaction price is at least $4.00 per share; otherwise, unvested equity is forfeited.
Outlook and Risks: The filing does not provide specific financial guidance or operational outlook. The primary risk disclosed relates to the transition of leadership and the financial obligations associated with the new executive's employment agreement, including potential severance costs in the event of a Change of Control.
Investor Verification Checklist
- Verify the effective date of the leadership transition (September 28, 2026) and the immediate impact on company operations.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason."
- Assess the dilution impact of the initial equity grants (250,000 RSAs and up to 250,000 PSUs) relative to total shares outstanding.
- Monitor the company's stock price relative to the $4.00 per share threshold required for the $1.5 million Change of Control cash bonus.
- Confirm the status of the interim leadership period and any pending strategic decisions made by the former Interim CEO.